-
$0
0.0% of portfolio
-
Q2 2024
Added 17.31%
$1.22B
$103 Million
0.0% of portfolio
13,693,132
Q2 2024
Added 1.05%
$8.78B
$163 Million
0.0% of portfolio
2,692,329
Q2 2024
Added 3.29%
$2.52B
$90.3 Million
0.0% of portfolio
26,710,194
Q2 2024
Added 55.02%
$20B
$18.3 Million
0.0% of portfolio
493,553
Q2 2024
Added 7.52%
-
$0
0.0% of portfolio
-
Q2 2024
Added 5.74%
$812M
$51.6 Million
0.0% of portfolio
2,226,904
Q2 2024
Added 4.14%
$0
$2.39 Million
0.0% of portfolio
206,701
Q2 2024
Added 0.24%
$0
$3.19 Million
0.0% of portfolio
421,966
Q2 2024
Added 12.88%
$218M
$1.54 Million
0.0% of portfolio
74,815
Q2 2024
Reduced 83.12%
-
$0
0.0% of portfolio
-
Q2 2024
Added 24.67%
$6.02B
$208 Million
0.0% of portfolio
2,200,275
Q2 2024
Added 3.9%
$1.16B
$205 Million
0.0% of portfolio
14,882,654
Q2 2024
Reduced 1.14%
$920M
$81.3 Million
0.0% of portfolio
2,708,831
Q2 2024
Reduced 0.07%
$165M
$7.34 Million
0.0% of portfolio
251,266
Q2 2024
Added 397.68%
$368M
$26.5 Million
0.0% of portfolio
581,823
Q2 2024
Added 17.74%
$34M
$16.6 Million
0.0% of portfolio
1,038,761
Q2 2024
Added 32.93%
-
$0
0.0% of portfolio
-
Q1 2024
New
$1.13B
$62.9 Million
0.0% of portfolio
3,870,887
Q2 2024
Added 16.81%
-
$0
0.0% of portfolio
-
Q2 2024
Added 2.78%
$185M
$13.4 Million
0.0% of portfolio
4,622,811
Q2 2024
Added 4.8%
$2.07B
$81.5 Million
0.0% of portfolio
10,414,979
Q2 2024
Reduced 6.9%
-
$0
0.0% of portfolio
-
Q2 2024
New
$137M
$8.64 Million
0.0% of portfolio
853,163
Q2 2024
Added 210.01%
$121M
$174,000
0.0% of portfolio
19,662
Q2 2024
Added 10.11%
$51.8M
$323,000
0.0% of portfolio
83,254
Q2 2024
Added 37.13%
$744M
$10.8 Million
0.0% of portfolio
2,075,121
Q2 2024
Added 8.53%
$240M
$3.85 Million
0.0% of portfolio
3,292,113
Q2 2024
Added 0.35%
Perspective Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2024
New
$768M
$33.4 Million
0.0% of portfolio
8,846,601
Q2 2024
Added 23.49%
$908M
$66.4 Million
0.0% of portfolio
3,009,661
Q2 2024
Added 2.73%
$105M
$2.25 Million
0.0% of portfolio
555,686
Q2 2024
Reduced 68.13%
-
$164 Million
0.0% of portfolio
12,468,272
Q2 2024
Reduced 6.63%
$92.7B
$211 Million
0.0% of portfolio
14,584,262
Q2 2024
Added 24.79%
Petros Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 0.51%
$33M
$26,000
0.0% of portfolio
13,346
Q2 2024
Reduced 36.76%
$599M
$42,000
0.0% of portfolio
2,268
Q3 2023
Added 1,353.85%
$248M
$30.1 Million
0.0% of portfolio
2,926,373
Q2 2024
Added 6.59%
$447M
$58.8 Million
0.0% of portfolio
3,504,466
Q2 2024
Reduced 2.78%
-
$0
0.0% of portfolio
-
Q2 2024
Added 19.83%
Phio Pharmaceuticals Corp
-
$0
0.0% of portfolio
-
Q1 2023
New
$1.52B
$108 Million
0.0% of portfolio
5,095,623
Q2 2024
Added 22.59%
-
$0
0.0% of portfolio
-
Q2 2024
Added 8.78%
$140M
$1.23 Million
0.0% of portfolio
378,026
Q2 2024
Added 0.46%
$154M
$14.1 Million
0.0% of portfolio
1,413,782
Q2 2024
Reduced 0.35%
$879M
$123 Million
0.0% of portfolio
16,928,899
Q2 2024
Reduced 0.03%
Pieris Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2024
New
$11B
$163 Million
0.0% of portfolio
4,222,799
Q2 2024
Added 6.27%
-
$0
0.0% of portfolio
-
Q2 2024
New
$0
$0
0.0% of portfolio
304,551
Q2 2024
Added 2.47%